MetabERN Member Spotlight: ROCAH Clinical Emergency Hospital for Children, Cluj-Napoca 🇷🇴
Romania's pioneering metabolic center - The Clinical Emergency Hospital for Children in Cluj-Napoca has been at the forefront of lysosomal disease care in Romania since 1997, when they introduced the first specific molecular diagnosis for Gaucher disease in the country. This groundbreaking center has since become the national reference point for inherited metabolic disorders.
🔬 National pioneering leadership:
Historic Milestone: Introduced Romania's first molecular diagnosis for Gaucher disease in 1997, marking the beginning of modern metabolic medicine in the country.
Triple National Role:
- Regional Centre for Medical Genetics in Cluj
- National Reference Centre for Inherited Metabolic Disorders - Lysosomal Diseases
- National Reference Centre for Rare Endocrine Disorders - Congenital Adrenal Hyperplasia
National Impact: Most Romanian patients with lysosomal disorders have been investigated at this center, with 200+ patients diagnosed and 120+ patients currently receiving specific treatment.
🌟 Comprehensive patient coverage:
Complete Lysosomal Care: Follows all Romanian patients with:
- MPS type I (Hurler disease) and MPS type II (Hunter disease)
- Alpha-mannosidosis and Gaucher disease
- Twice-yearly monitoring for optimal care coordination
Treatment Timeline Excellence:
- Gaucher disease: Imiglucerase enzyme replacement since 2003
- MPS I: Laronidase treatment since 2005
- MPS II: Idursulfase therapy since 2011
- Alpha-mannosidosis: Enzyme replacement since 2020
🎯 Advanced diagnostic and research capabilities:
Diagnostic Excellence: Enzyme activity measurement and genetic testing supported by affiliated Medical Genetic Laboratory and specialized imaging with ultrasounds, MRI, CT scans by experts in lysosomal disorders.
University Partnership: Collaboration with "Iuliu Hațieganu" University of Medicine and Pharmacy enables high-throughput sequencing and metabolomic research opportunities.
National Healthcare Integration: All treatments supported by National Health Insurance House through the National Program for Rare Diseases, ensuring accessibility for Romanian families.
Professional Development:
- National clinical practice guidelines development (Gaucher, MPS I/II, Tyrosinemia, Pompe disease)
- Regional examination board participation for specialty and senior physicians
- Medical staff training programs for inherited metabolic disorder recognition
International Integration:
- Collaboration with international registries for Gaucher disease, MPS I, MPS II
- Epidemiological data collection providing concrete and representative patient information
- Multidisciplinary approach with genetic counseling services
Cluj-Napoca demonstrates how one center's pioneering vision can transform an entire country's approach to rare disease care, establishing Romania as an active participant in European metabolic medicine. 💙
Learn more: https://metab.ern-net.eu/hcp/clinical-emergency-hospital-for-children-cluj-napoca/
#MetabERN #RareDiseases #Romania #ClujNapoca #LysosomalDisorders #GaucherDisease #MPS #PioneeringCare #Healthcare
Posted Apr 6, 2026, 1:28 PM UTC